PSA testing has improved prostate cancer survival, scientists say

24 august 2012

Prostate cancer survival rates have improved since the introduction of prostate specific antigen (PSA) testing, research has revealed.

A study published in the Journal of Urology found that the routine use of PSA testing has resulted in earlier and more sensitive detection of the disease.

Furthermore, survival has increased for patients who have prostate cancer that has just been diagnosed and has spread to other parts of the body.

Lead investigator Ian M Thompson Jr, added: "Our analysis indicates an overall improvement in risk adjusted survival rates for non-African American and African American men. Of note is the resolution of disparity in survival between the races found in earlier studies."

There was found to be a 30 per cent decreased risk of death in the most recent trial, which enrolled patients from 1995 to 2009, compared to the previous one, which took place between 1989 and 1994.

Posted by Philip Briggs

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)